Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine for Pain After Total Shoulder Replacement
NCT04134442Phase 4Withdrawn
- Sponsor
- University of Massachusetts
- Start
- Dec 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by University of Massachusetts. Primary endpoint: Morphine Equivalent Dose of Opioids at 24 hours. Planned start Dec 2019; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04134442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04134442.